TORL BioTherapeutics logo

TORL BioTherapeutics Funding & Investors

Culver City, CA

TORL BioTherapeutics is a clinical-stage biopharmaceutical business focused on creating innovative, antibody-based medicines to improve the lives of cancer patients. They are developing a comprehensive pipeline of innovative preclinical ADCs and mAb in oncologic diseases with high unmet medical needs.

torlbio.com

Total Amount Raised: $412,000,000

TORL BioTherapeutics Funding Rounds

  • Series C

    $96,000,000

  • Series B

    $158,000,000

    Series B Investors

    Deep Track Capital
    RA Capital Management
    Bristol-Myers Squibb Company
    Vertex Ventures HC
    Avidity Partners Management
    Blue Owl Capital
    Moore Strategic Ventures
    Goldman Sachs
    University of California Office of the President
    Perceptive Advisors
    Xontogeny
    UC Investments
    Gianna Hoffman-Luca

  • Series B

    $158,000,000

    Series B Investors

    Goldman Sachs Asset Management
    Cowen Healthcare Investments
    Vertex Ventures HC
    Moore Strategic Ventures
    Bristol-Myers Squibb Company
    Alexandria Real Estate Equities
    Deep Track Capital
    OCV
    UC Investments
    Perceptive Advisors
    Vest Coast Capital
Funding info provided by Diffbot.